Multidrug Resistance: In Situ shRNA Synthesis on DNA-Polylactide Nanoparticles to Treat Multidrug Resistant Breast Cancer (Adv. Mater. 10/2018)

Advanced Materials - United States
doi 10.1002/adma.201870064
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Multidrug Resistance in Prostate Cancer

Oncology Research and Treatment
Cancer ResearchOncologyHematology
2003English

Fluoroquinolone Resistance in Multidrug-Resistant Tuberculosis Patients

Korean Journal of Internal Medicine
Internal Medicine
2019English

Modulation of Intracellular Ceramide Using Polymeric Nanoparticles to Overcome Multidrug Resistance in Cancer

Cancer Research
Cancer ResearchOncology
2007English

Nanomicellar Paclitaxel Increases Cytotoxicity of Multidrug Resistant Breast Cancer Cells

Cancer Letters
Cancer ResearchOncology
2009English

New Drugs to Treat Multidrug-Resistant Tuberculosis: The Case for Bedaquiline

Therapeutics and Clinical Risk Management
2014English

Mechanism of Action of Substituted Indanones in Multidrug Resistant Breast Cancer

2000English

Mechanism of Action of Substituted Indanones in Multidrug Resistant Breast Cancer

2001English

Masthead: (Adv. Electron. Mater. 10/2018)

Advanced Electronic Materials
OpticalElectronicMagnetic Materials
2018English

Masthead: (Adv. Funct. Mater. 10/2018)

Advanced Functional Materials
Materials ScienceCondensed Matter PhysicsElectrochemistryNanoscienceOpticalBiomaterialsMagnetic MaterialsNanotechnologyChemistryElectronic
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy